NU:NYSE
Nu Holdings Ltd.
Data as of 2026-03-10 - not real-time
$14.67
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Nu Holdings is trading near a key support level with the Relative Strength Index in the low‑30s, suggesting the stock may be oversold, while the MACD remains bearish, indicating continued downside pressure in the short term. Fundamentally, the company delivers strong revenue growth and robust operating margins, yet its trailing P/E sits well above the industry average, pointing to a premium valuation. The forward P/E, however, is considerably lower, implying that earnings are expected to accelerate and the current price may be more justified on a forward basis. Volatility is elevated, and beta exceeds one, reflecting heightened sensitivity to market swings, especially given the regional banking sector’s exposure to economic cycles. Despite these headwinds, the balance sheet shows ample cash relative to debt, and the analyst consensus is overwhelmingly positive with a strong‑buy rating.
The upside potential estimated by analysts exceeds 30%, while the market sentiment index signals extreme greed, indicating strong investor appetite. The combination of a solid growth narrative, improving earnings outlook, and attractive upside suggests that the stock could rebound if technical pressures ease, making it a compelling candidate for investors with a medium‑to‑long horizon.
The upside potential estimated by analysts exceeds 30%, while the market sentiment index signals extreme greed, indicating strong investor appetite. The combination of a solid growth narrative, improving earnings outlook, and attractive upside suggests that the stock could rebound if technical pressures ease, making it a compelling candidate for investors with a medium‑to‑long horizon.
Trading Recommendations
Short Term
< 1 yearhold
Conviction: 7/10
Key Factors
- Oversold RSI indicating potential near‑term bounce
- Bearish MACD signaling continued downside risk
- Proximity to technical support level
Medium Term
1–3 yearsbuy
Conviction: 8/10
Key Factors
- Strong revenue growth and high operating margins
- Forward P/E discount relative to trailing valuation
- Analyst consensus of strong‑buy and sizable upside estimate
Long Term
> 3 yearsbuy
Conviction: 9/10
Key Factors
- Robust cash position and manageable debt profile
- Expanding digital banking footprint across Latin America and the U.S.
- Sustained earnings growth potential underpinning long‑term value
Key Metrics & Analysis
Financial Health
Revenue Growth43.90%
Profit Margin41.04%
P/E Ratio24.9
ROE30.28%
ROA4.60%
P/B Ratio6.3
Op. Cash Flow$-9360818176
Industry P/E17.4
Technical Analysis
TrendNeutral
RSI33.0
Support$14.17
Resistance$17.99
MA 20$16.18
MA 50$16.92
MA 200$15.08
MACDBearish
VolumeIncreasing
Fear & Greed Index75.89
Valuation
Target Price$20.17
Upside/Downside37.51%
GradeFair
TypeBlend
Risk Assessment
Beta1.14
Volatility49.30%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
More Tickers
This analysis may contain inaccuracies. Not financial advice. Always do your own research before making any investment decisions.